In multiple-dose bioequivalence studies, it is possible at steady state to take repeated measurements of pharmacokinetic variables, such as area under the curve (AUC) and the maximum concentration (CMAX) of the blood concentration-time profile, within each period of a crossover design. We develop a bivariate random effects model for such a situation in a 2 x 2 crossover design using the natural.
|Original language||English (US)|
|Number of pages||13|
|Journal||Journal of Biopharmaceutical Statistics|
|State||Published - Jan 1 1994|
All Science Journal Classification (ASJC) codes
- Statistics and Probability
- Pharmacology (medical)